Oxford peptide patients tend to be either athletes (running, lifting, CrossFit) looking for recovery and joint support, or 40+ patients stacking BPC-157 or growth-hormone-releasing peptides alongside their TRT or weight-loss protocol
Maintain a list of sulfa drugs and always check with your pharmacist if a new medication is safe to use
Retatrutide, which has not yet completed clinical trials, is an experimental injection developed by the US drugmaker Eli Lilly that targets three gut hormones: GLP-1, GIP and glucagon
and the dopamine agonist bromocriptine (Cycloset)
Here's how they stack up on the things that actually matter for GLP-1 users
DT received lecture or consultancy fees from Amarin, AstraZeneca, Eli Lilly, and Novo Nordisk